Cancer Genomics Consortium
LightNews LightNews
banner
cgconsortium.bsky.social
Cancer Genomics Consortium
@cgconsortium.bsky.social
91 followers 180 following 190 posts
Cancer Genomics Consortium (CGC) is a 501(c)3 non-profit organization whose mission is to providing high quality education and promoting best practices in clinical cancer genomics.
Posts Replies Media Videos
cgconsortium.bsky.social
Q26. Which of the following abnormalities are defined as high risk in newly diagnosed patients with multiple myeloma?:

A. 1p32 gain
B. t(4;14)
C. t(11;14)
D. Trisomy 8
November 13, 2025 at 3:04 PM
cgconsortium.bsky.social
Join us in congratulating Ninette Cohen, PhD, FACMG who is being featured in our November #CGCspotlight! Ninette is a member of the Communications Committee where she serves as chair of the website subcommittee. Learn more here: buff.ly/5sGAxRY

#CGCVolunteers #genomics #cancer #research #genetics
November 11, 2025 at 5:11 PM
cgconsortium.bsky.social
Registration Now Open: The Cancer Genomics Consortium (CGC) invites you to attend Circulating Tumor DNA as Diagnostic Tool in Oncology on December 11, 2025. Click here to register: buff.ly/9E1KZio

#CGCVolunteers #genomics #cancer #research #genetics #clinicaltesting #bioinformatics #cytogenetics
November 10, 2025 at 3:04 PM
cgconsortium.bsky.social
Q26. Which of the following abnormalities are defined as high risk in newly diagnosed patients with multiple myeloma?:
A. 1p32 gain
B. t(4;14)
C. t(11;14)
D. Trisomy 8

Type your answer in the chat below and come back next week for the answer and explanation!
November 6, 2025 at 3:01 PM
cgconsortium.bsky.social
Mark your calendar with #CGCAnnual2026—we look forward to seeing you in Houston next year!

#CGCAnnual2026 #genomics #cancer #research #genetics #clinicaltesting #bioinformatics #cytogenetics #molecular
November 5, 2025 at 3:03 PM
cgconsortium.bsky.social
The Education Committee is comprised of dedicated members who are committed to providing varied and interesting educational resources to our members throughout the year. We always welcome suggestions and feedback from members. Learn more about the committees here: buff.ly/q0FY6mo

#CGCVolunteers
November 4, 2025 at 3:03 PM
cgconsortium.bsky.social
Final Day! Help shape the program for the Cancer Genomics Consortium 2026 Annual Meeting! The Cancer Genomics Consortium is soliciting proposals for invited sessions for the 17th Annual Meeting in Houston, TX.

#CGCAnnual2026 #genomics #cancer #research #genetics #clinicaltesting #bioinformatics
October 30, 2025 at 2:05 PM
cgconsortium.bsky.social
Q25. A diffuse astrocytic glioma arising in 65-year-old patient is found to be IDH-wild type and H3-wild type, what is a defining genetic feature of glioblastoma, IDH-wild type, CNS WHO grade 4?

A. Gain of chromosome 10
B. TERT promoter mutation
C. EGFR gene amplification
D. B and C
October 28, 2025 at 2:06 PM
cgconsortium.bsky.social
A quick reminder to join us tomorrow for "Transforming Tumor Methylation Profiling with Oxford Nanopore Direct DNA Sequencing." Click here to learn more and register today: buff.ly/Oxz6OQh
October 27, 2025 at 2:06 PM
cgconsortium.bsky.social
Help shape the program for the Cancer Genomics Consortium 2026 Annual Meeting! The Cancer Genomics Consortium is soliciting proposals for invited sessions for the 17th Annual Meeting in Houston, TX.

#CGCAnnual2026 #genomics #cancer #research #genetics #clinicaltesting #bioinformatics #cytogenetics
October 23, 2025 at 2:05 PM
cgconsortium.bsky.social
Join us next week for "Transforming Tumor Methylation Profiling with Oxford Nanopore Direct DNA Sequencing" on October 28, 2025. Click here to learn more and register today: buff.ly/Oxz6OQh
October 22, 2025 at 2:06 PM
cgconsortium.bsky.social
Q25. A diffuse astrocytic glioma arising in 65-year-old patient is found to be IDH-wild type and H3-wild type, what is a defining genetic feature of glioblastoma, IDH-wild type, CNS WHO grade 4?

A. Gain of chromosome 10
B. TERT promoter mutation
C. EGFR gene amplification
D. B and C
October 21, 2025 at 2:05 PM
cgconsortium.bsky.social
The Cancer Genomics Consortium (CGC) and Oxford Nanopore Technologies invite you to attend Transforming Tumor Methylation Profiling with Oxford Nanopore Direct DNA Sequencing on October 28, 2025. Click here to learn more and to register today: buff.ly/Oxz6OQh
October 16, 2025 at 3:16 PM
cgconsortium.bsky.social
Join us in congratulating Teresa A. Smolarek, PhD, FACMG who is being featured in our October #CGCspotlight! Teresa is a member of the Genomic Diagnosis of Sarcoma Working Group and the Education Committee. Learn more here: buff.ly/UkJ5OXS

#CGCVolunteers #genomics #cancer #research #genetics
October 14, 2025 at 4:34 PM
cgconsortium.bsky.social
Help shape the program for the Cancer Genomics Consortium 2026 Annual Meeting! The Cancer Genomics Consortium is soliciting proposals for invited sessions for the 17th Annual Meeting in Houston, TX.

#CGCAnnual2026 #genomics #cancer #research #genetics #clinicaltesting #bioinformatics #cytogenetics
October 13, 2025 at 2:05 PM
cgconsortium.bsky.social
Don't miss out! The new letter from the CGC President is here, sharing the latest vision and updates for the future of the Cancer Genomics Consortium. Read the full message now: buff.ly/iuQLfTt

#CGCAnnual2026 #genomics #cancer #research #genetics #clinicaltesting #bioinformatics #cytogenetics
October 9, 2025 at 7:04 PM
cgconsortium.bsky.social
Q24. Prader-Willi syndrome result from ______ in a majority of cases.

A. Imprinting defect
B. UPD15
C. Deletion
D. Path seq variant in UBE3A
October 9, 2025 at 5:06 PM
cgconsortium.bsky.social
Please join us on Tuesday, October 14, for the monthly Collaborative Genomics Case Conference Webinar. This event is a partnership between the University of Wisconsin-Madison ICEP and the Cancer Genomics Consortium. Learn more here:
buff.ly/bKZ6sKX

#genomics #cancer #research #genetics
October 8, 2025 at 7:03 PM
cgconsortium.bsky.social
CGC is dedicated to supporting the Early Career community with low trainee membership fees, outstanding early career programing, and incredible networking opportunities! CGC is the place to join for Early Career individuals in the Genetics and Genomics field.
October 7, 2025 at 2:04 PM
cgconsortium.bsky.social
Help shape the program for the Cancer Genomics Consortium 2026 Annual Meeting! The Cancer Genomics Consortium is soliciting proposals for invited sessions for the 17th Annual Meeting in Houston, TX.

#CGCAnnual2026 #genomics #cancer #research #genetics #clinicaltesting #bioinformatics #cytogenetics
October 6, 2025 at 4:06 PM
cgconsortium.bsky.social
Reminder: The CGC Early Career Committee will host a webinar on October 8, 2025 focused on digital networking for early career professionals. Click here to register now: buff.ly/9FUUBF8

#CGCAnnual2025 #genomics #cancer #research #genetics #clinicaltesting #bioinformatics #cytogenetics #molecular
October 3, 2025 at 2:05 PM
cgconsortium.bsky.social
Q24. Prader-Willi syndrome result from ______ in a majority of cases.

A. Imprinting defect
B. UPD15
C. Deletion
D. Pathogenic sequence variant in UBE3A

Type your answer in the chat below and come back next week for the answer and explanation!
October 2, 2025 at 5:06 PM
cgconsortium.bsky.social
Help shape the program for the Cancer Genomics Consortium 2026 Annual Meeting! The Cancer Genomics Consortium is soliciting proposals for invited sessions for the 17th Annual Meeting in Houston, TX. Click here to learn more: buff.ly/9LJ5mTV

#CGCAnnual2026 #genomics #cancer #research #genetics
September 29, 2025 at 3:05 PM
cgconsortium.bsky.social
The CGC Early Career Committee will host a webinar on October 8, 2025 focused on digital networking for early career professionals. Click here to register now: buff.ly/9FUUBF8

#CGCAnnual2025 #genomics #cancer #research #genetics #clinicaltesting #bioinformatics #cytogenetics #molecular
September 26, 2025 at 2:03 PM
cgconsortium.bsky.social
Help shape the program for the Cancer Genomics Consortium 2026 Annual Meeting! The Cancer Genomics Consortium is soliciting proposals for invited sessions for the 17th Annual Meeting in Houston, TX. Click here to learn more: buff.ly/zya2jw8

#CGCAnnual2026 #genomics #cancer #research #genetics
September 24, 2025 at 2:08 PM